Eric M. Ruderman, MD
Professor of Medicine
Associate Chief, Clinical Affairs
Division of Rheumatology
Feinberg School of Medicine
Joseph F. Merola, MD, MMSc
Assistant Professor of Medicine
Harvard Medical School
Director, Clinical Unit for Research Innovation and Trials (CUReIT)
Co-Director, Center for Skin and Related Musculoskeletal Diseases
Departments of Dermatology and Medicine
Division of Rheumatology
Brigham and Women's Hospital
Psoriatic arthritis (PsA) is a serious, inflammatory arthritis associated with psoriasis and multiple comorbidities that often goes undiagnosed and untreated. This activity will examine strategies for early recognition and referral, as well as specialty collaboration in the treatment of PsA.
Rheumatologists, dermatologists, and allied health care professionals involved in the treatment of patients with psoriasis and PsA.
Upon completion of this educational activity, the participant should be able to:
- Screen patients with psoriasis for inflammatory arthritides such as PsA.
- Describe the consequences of delaying rheumatology referral of patients with psoriasis who have PsA.
- Discuss the complementary skills and experience that a dermatologist and rheumatologist can each bring to the care of a patient with PsA.
- Describe effective methods of inter-specialty communication that facilitate co-management of psoriasis patients with PsA.
It is our policy to ensure balance, independence, objectivity, and scientific rigor in all of our educational programs. Faculty and course directors have disclosed relevant financial relationships with commercial companies, and Penn State has a process in place to resolve any conflict of interest.
Dr. Ruderman has disclosed the following:
Consultant/Advisor: AbbVie, Amgen, BMS, Celltrion, Janssen, Lilly, Novartis, Pfizer
Research Grant: Pfizer
Dr. Merola has disclosed the following:
Speakers Bureau: AbbVie
Consultant/Advisor: AbbVie, Amgen, Biogen, GSK, Janssen, Kiniksa, Lilly, Mallinckrodt, Momenta, Novartis, Pfizer, Sanofi, Samumed, Science 37, UCB
Penn State staff involved in the development and review of this activity have nothing to disclose.
MCM Education staff involved in the development and review of this activity have nothing to disclose.
Faculty members are required to inform the audience when they are discussing off-label or unapproved uses of devices or drugs. Devices or drugs that are still undergoing clinical trials are identified as such and should not be portrayed as standard, accepted therapy. Please consult full prescribing information before using any product mentioned in this activity. If using products in an investigational, off-label manner, it is the responsibility of the prescribing physician to monitor the medical literature to determine recommended dosages and uses of the drugs. Neither the publisher nor the providers promote the use of any agent outside of approved labeling.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Penn State College of Medicine and MCM Education. Penn State College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
CREDIT DESIGNATION STATEMENT
Penn State College of Medicine designates this enduring activity for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For questions regarding CME credit, contact Penn State Continuing Education at 717-531-6483 or ContinuingEd@hmc.psu.edu. Please reference activity code G6139-18-T.
Commercial Support Statements
This activity is supported by independent educational grants from Novartis and AbbVie.
- Computer Requirements: Minimum System Requirements: • Pentium III, 600 MHz or Equivalent Processor • 512 MB of RAM • Windows XP, Vista, or 7 • Mac OS X • 800x600 Monitor Resolution • 16-bit Color • 16 bit Sound Card with Speakers
- Accessing Activity:
* Click "Start Program"
* Take the pre-test
* Review the activity
* Take the post-test and score 80%
* You are allowed a total of 3 attempts
* Complete the evaluation
* View, print, or save a CME certificate verifying your credit/participation in this activity
The opinions expressed in this educational activity are those of the faculty and do not necessarily reflect the opinions or recommendations of their affiliated institutions; the publisher; Penn State College of Medicine; Novartis; or AbbVie. Any medications, diagnostic procedures, or treatments discussed by the program presenters should not be used by clinicians or other health care professionals without first evaluating their patients’ conditions, considering possible contraindications or risks, reviewing any applicable manufacturer’s product information, and comparing any therapeutic approach with the recommendations of other authorities.